READ FULL VERSION OF THE CODE OF ETHICS FOR THE PROMOTION OF MEDICINES
"The future of healthcare: exchange of Swedish and Kazakh experiences in managing the healthcare system" round table was held in Astana with participation of Kazakhstan Ministry of Health and Swedish National Board of Health and...
The Ministry of Industry and Trade of the Russian Federation proposes from January 1, 2021 to register new drugs for medical use only within the framework of the rules of the Eurasian Economic Union, the press service of the
Gilead has announced that its investigational rheumatoid arthritis (RA) drug, filgotinib, has proved successful in a trial evaluating its efficacy and safety when treating moderately-to-severely active versions of the
The U.S. Food and Drug Administration authorized marketing of a new diagnostic test based on bacterial viability and novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacterial
Novartis said Thursday ahead of a meeting with analysts and investors that it expects to submit more than 80 major marketing applications for its drugs from 2020 to 2022 in the US, Europe, Japan and China. CEO Vas Narasimhan
AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration to develop new therapies for a range of
On public health and health care system (Unofficial translation)
AMFP in Kazakhstan is a non-profit organization and is in the Kazakhstan market professional and business interests of international pharmaceutical companies - manufacturers of drugs and medical equipment.
The Association was established in March 1999. Its current membership includes more than 50 of the largest pharmaceutical companies in the world.